J&J’s New Drug for Treatment-Resistant Depression
May 4, 2026
1,426
42
4
3.23%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg News Episodes Around May 4, 2026
See what was published immediately before and after this episode.
2:00Now PlayingJ&J’s New Drug for Treatment-Resistant Depression
YouTube Description
as posted by the channelSpravato is a ketamine-derivative used to treat patients who have been diagnosed with drug-resistant depression. Madison Mueller explains how it works and why you’re probably only just now hearing about it. #health #depression #mentalhealth #usa
----------
Like this video? Subscribe
Bloomberg News is the first word in business news. Visit bloomberg.com for the latest on global business, markets and more.
Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months
Bloomberg on YouTube:
Connect with us on social:
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.